T3	Effect 0 17	Myasthenia gravis
T7	Dosage 25 33	low-dose
T8	Drug 34 43	IFN-alpha
T9	Treat-Disorder 56 75	chronic hepatitis C
T4	Treatment 25 51	low-dose IFN-alpha therapy
T5	Adverse_event 18 24	during
E1	Adverse_event:T5